Polycystic ovary syndrome

Archives of Disease in Childhood

Volumn 77, Issue 1, 1997, Pages 89-90

  Franks, Stephen ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; LUTEINIZING HORMONE; TESTOSTERONE;

ADOLESCENT; ARTICLE; FEMALE; HUMAN; METABOLISM; OVARY; OVARY POLYCYSTIC DISEASE; PATHOLOGY;

ADOLESCENT; ANDROGEN ANTAGONISTS; CYPROTERONE ACETATE; FEMALE; HUMANS; LUTEINIZING HORMONE; OVARY; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE;

EID: 0031181423     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.77.1.89     Document Type: Article

References (15)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-61.
2. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165-74.
3. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992; 37: 119-25.
4. Robinson S, Henderson AD, Gelding SV, et al. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol fOx/91996; 44: 277-84.
5. Dahlgren E, Johansson S, Lindstedt G, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Ferril Steril 1992; S7: 505-13.
6. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction-evaluated from a risk factor model based on a prospective study of women. Acta Obstet Gynecol Scand 1992; 71: 599-604.
7. Poison DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries -a common finding in normal women. Lancet 1988; i: 870-2.
8. Simpson J L. Elucidating the genetics of polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Oxford: Blackwell Scientific Publications, 1992: 59-77.
9. Waterworth D, Bennett S, Gharani N, et al. Linkage and association of the insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997 (in press).
10. Gharani N, Waterworth DM, Batty S, et al. Association of the steroid metabolising gene CYPlla with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997 (in press).
11. Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle stimulating and luteinizing hormone action in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996; 81: 302-9.
12. Bridges NA, Cooke A, Healy MJR, Hindmarsh PC, Brook CGD. Standards for ovarian volume in childhood and puberty. Fertil Steril 1993; 60: 456-60.
13. Zumoff B, Freeman R, Coupey S, Saenger P, Markowitz M, Kream J. A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with polycystic ovary syndrome. N Engl J Med 1983; 309: 1206-9.
14. Stanhope R, Adams J, Pringle JP, Jacobs HS, Brook CG. The evolution of polycystic ovaries in a girl with hypogonadotropic hypogonadism before puberty and during puberty induced with pulsatile gonadotropin-releasing hormone. Fertil Steril 1987; 47: 872-5.
15. Holly JMP, Smith CP, Dunger DB, et al. Relationship between the fall in sex hormone-binding globulin and insulin-like growth factor binding protein-I. A synchronized approach to pubertal development? Clin Endocrinol (Oxj) 1989; 31: 277-84.